Related Experiment Video
Updated: May 27, 2026
Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
Published on: May 26, 2015
Does catheter ablation for atrial fibrillation increase or reduce neurological insult?
1Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada. Jeff.Healey@Phri.ca
Insights
Catheter ablation for atrial fibrillation carries a risk of stroke, with silent brain infarcts being far more common than clinically apparent strokes. Understanding these neurological risks helps refine ablation techniques to potentially reduce stroke incidence.
Area of Science:
- Cardiology
- Neurology
- Medical Technology
Background:
- Medication-based rhythm control for atrial fibrillation has not shown stroke reduction benefits.
- Catheter ablation is a potential alternative for stroke prevention in atrial fibrillation patients.
- Neurological complications, including stroke, are a known risk of catheter ablation.
Purpose of the Study:
- To review the periprocedural and long-term neurological risks associated with catheter ablation for atrial fibrillation.
- To evaluate the incidence and impact of stroke and silent cerebral infarction.
- To explore how understanding neurological injury refines ablation techniques.
Main Methods:
- Review of randomized trials and observational studies on catheter ablation for atrial fibrillation.
- Analysis of data from magnetic resonance imaging (MRI) studies detecting silent cerebral infarction.
- Evaluation of studies screening for silent cerebral infarction to refine ablation techniques.
Main Results:
- Randomized trials of rhythm control medications for atrial fibrillation have not reduced stroke risk.
- Catheter ablation for atrial fibrillation carries a periprocedural stroke risk.
- Silent cerebral infarction is approximately 10 times more common than clinical stroke, detected by MRI.
- Silent infarcts may be linked to adverse long-term neuropsychological outcomes.
Conclusions:
- Understanding neurological injury refines catheter ablation techniques for atrial fibrillation.
- Further clinical trials are needed to confirm if catheter ablation reduces stroke risk.
- Refined ablation techniques aim to improve patient outcomes and potentially prevent stroke.
Purpose Of Review:
This article will review the periprocedural and long-term risk of stroke and other adverse neurological outcomes in patients having catheter ablation of atrial fibrillation.
Recent Findings:
Randomized trials of medication-based rhythm control for atrial fibrillation have failed to demonstrate a reduction in stroke. There is hope that catheter ablation of atrial fibrillation may provide such a benefit; however, definitive clinical trials have yet to be completed. It is well established that catheter ablation of atrial fibrillation is associated with a risk of periprocedural stroke; however, new studies using magnetic resonance imaging suggest that silent cerebral infarction is 10 times more common than clinical stroke. Studies which have systematically screened for silent cerebral infarction have been invaluable in refining the technique of atrial fibrillation catheter ablation, by identifying procedural details and ablation technologies which are more likely to result in this surrogate outcome. There is also early suggestion that these silent infarctions may be associated with longer-term adverse neuropsychological outcomes.
Summary:
A more precise understanding of neurological injury with catheter ablation of atrial fibrillation is helping to refine this technique and will ultimately help determine if the prevention of recurrent atrial fibrillation with catheter ablation can reduce the risk of stroke.
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
01:25Dysrhythmias VI: Management of Dysrhythmias